Cyclopropyl-(hetero)aryl-substituted ethylsulphonyl-pyridine derivatives

A compound selected from the group consisting of formula (II) or formula (III):

• wherein:
• W1, W2, W3, W4, W5 are each independently N, C or C—H, and at most three of W1, W2, W3, W4, W5 are N;
• is attached to a C atom;
• R, R1a, R1b, R2a, R2b, R3 are each independently hydrogen, halogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, aryl, C1-C6-alkoxy, C1-C6-haloalkoxy, OH, CN, C(O)ORv, S(O)r—(C1-C6-alkyl), S(O)s—(C1-C6-haloalkyl), S(O)t—Rw, S(O)2—N(Rx)(Ry), S(O)—(Rw)═N—Rz, wherein R3, if present once or more times, in each occurrence is independently attached to a C atom, or wherein R together with R1a or R1b forms an unsubstituted or substituted carbocycle or an unsubstituted or substituted heterocycle, and such carbocycle or heterocycle if substituted is independently substituted with one, two or three substituents each independently selected from the group consisting of halogen, alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, aryl, C1-C6-alkoxy, C1-C6-haloalkoxy, OH, CN, C(O)ORx, S(O)r—(C1-C6-alkyl), and S(O)s—(C1-C6-haloalkyl);
• Rv, Rw, Rx, Ry, Rz in each occurrence are independently selected from the group consisting of hydrogen, halogen, C1-C6-alkyl, and C1-C6-haloalkyl;
• n is 0, 1, 2, 3, 4;
• r, s, t in each occurrence independently are 0, 1 or 2;
• the dashed bond () signifies a single or double bond;
• and
• Z is halogen, C(O)—OH, C(O)-halogen, or C(O)—O—(C1-C6)-alkyl;
• or a pharmaceutically acceptable salt thereof.